EU Committee Backs Pfizer-BMS Anti-Clotting Drug
The recommendation, from the EMA's Committee for Medicinal Products for Human Use, will be reviewed by European regulators. If they adopt the recommendation, the drug, Eliquis, will be approved throughout the European Union, as well as Iceland and Norway, the companies said.
Eliquis, known by the generic name apixaban, is already approved in Europe for the prevention of...
To view the full article, register now.